Crizotinib and erlotinib inhibits growth of c-Met+/EGFRvIII+ primary human glioblastoma xenografts-Reference-Cited by-同舟云学术

Crizotinib and erlotinib inhibits growth of c-Met+/EGFRvIII+ primary human glioblastoma xenografts

Published:2018-08 Issue: Volume:171 Page:26-33
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Goodwin C. Rory,Rath Prakash,Oyinlade Olutobi,Lopez Hernando,Mughal Salman,Xia Shuli,Li Yunqing,Kaur Harsharan,Zhou Xin,Ahmed A. Karim,Ho Sandra,Olivi Alessandro,Lal Bachchu

Funder

United Negro College Fund/Merck Science Initiative

Neurosurgery Research and Education Foundation

Burroughs Wellcome Fund

Publisher

Elsevier BV

Subject

Neurology (clinical),General Medicine,Surgery

Reference25 articles.

1. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis;Abounader;FASEB J.,2002

2. Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells;Bergstrom;Exp. Cell Res.,2000

3. Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery;Carlson;Curr. Protoc. Pharmacol.,2011

4. Prospective, high-throughput molecular profiling of human gliomas;Chi;J. Neurooncol.,2012

5. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling;Engelman;Science,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Searching Prognostic Hub Genes for the Management of Gliomagenesis through Transcriptome Profiling;2024-02-06

2. Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia;Biomedicine & Pharmacotherapy;2024-01

3. Cyanine Dye Conjugation Enhances Crizotinib Localization to Intracranial Tumors, Attenuating NF-κB-Inducing Kinase Activity and Glioma Progression;Molecular Pharmaceutics;2023-11-08

4. From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress;Signal Transduction and Targeted Therapy;2023-10-20

5. Zebrafish Drug Screening Identifies Erlotinib as an Inhibitor of Wnt/β-Catenin Signaling and Self-Renewal in T-cell Acute Lymphoblastic Leukemia;2023-08-28